3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Neoplasm Metastasis
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Neuroendocrine
1
Anophthalmia with pulmonary hypoplasia
1
Interventions
Cisplatin
4
Cetuximab
4
pembrolizumab
3
Radiotherapy
3
cemiplimab
2
Surveys and Questionnaires
2
Magnetic Resonance Spectroscopy
2
Carboplatin
2
olaparib
1
niraparib
1
fludarabine
1
dostarlimab
1
calcipotriene
1
avelumab
1
atezolizumab
1
alpha-2'-deoxythioguanosine
1
aldesleukin
1
Watchful Waiting
1
Tiragolumab
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Platinum
1
Phlebotomy
1
Paclitaxel
1
Nivolumab
1
Lidocaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
budigalimab
×
30 days
×
Clear all
No trials found.